These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28091594)

  • 1. Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing.
    Zhao J; Sun Y; Huang Y; Song F; Huang Z; Bao Y; Zuo J; Saffen D; Shao Z; Liu W; Wang Y
    Sci Rep; 2017 Jan; 7():40488. PubMed ID: 28091594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H.
    Zhang S; Bao Y; Shen X; Pan Y; Sun Y; Xiao M; Chen K; Wei H; Zuo J; Saffen D; Zong WX; Sun Y; Wang Z; Wang Y
    EBioMedicine; 2020 Nov; 61():103067. PubMed ID: 33130397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay.
    Sun Y; Bao Y; Han W; Song F; Shen X; Zhao J; Zuo J; Saffen D; Chen W; Wang Z; You X; Wang Y
    Nucleic Acids Res; 2017 Aug; 45(14):8524-8540. PubMed ID: 28586478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of RBM10 mutations in the development, treatment, and prognosis of lung adenocarcinoma.
    Li Z; Xue Q; Xu J; Zhang P; Ding B
    Cell Cycle; 2020 Nov; 19(21):2918-2926. PubMed ID: 33064970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition.
    Bao Y; Zhang S; Zhang X; Pan Y; Yan Y; Wang N; Ren Y; Zuo J; Zong WX; Wang Z; Wang Y
    Cancer Res; 2023 May; 83(9):1490-1502. PubMed ID: 36853175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.
    Zhang L; Li S; Choi YL; Lee J; Gong Z; Liu X; Pei Y; Jiang A; Ye M; Mao M; Zhang X; Kim J; Chen R
    Lung Cancer; 2017 Jul; 109():21-27. PubMed ID: 28577945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor properties of the splicing regulatory factor RBM10.
    Hernández J; Bechara E; Schlesinger D; Delgado J; Serrano L; Valcárcel J
    RNA Biol; 2016; 13(4):466-72. PubMed ID: 26853560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-binding motif protein 10 represses tumor progression through the Wnt/β- catenin pathway in lung adenocarcinoma.
    Cao Y; Geng J; Wang X; Meng Q; Xu S; Lang Y; Zhou Y; Qi L; Wang Z; Wei Z; Yu Y; Jin S; Pan B
    Int J Biol Sci; 2022; 18(1):124-139. PubMed ID: 34975322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RBM10, a New Regulator of p53.
    Jung JH; Lee H; Zeng SX; Lu H
    Cells; 2020 Sep; 9(9):. PubMed ID: 32947864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of
    Cao Y; Lan D; Ke X; Zheng W; Zeng J; Niu N; Fu C; Deng W; Jin S
    Heliyon; 2024 Jun; 10(11):e32287. PubMed ID: 38912481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site.
    Tessier SJ; Loiselle JJ; McBain A; Pullen C; Koenderink BW; Roy JG; Sutherland LC
    BMC Res Notes; 2015 Feb; 8():46. PubMed ID: 25889998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing DNA replication stress to target RBM10 deficiency in lung adenocarcinoma.
    Machour FE; R Abu-Zhayia E; Kamar J; Barisaac AS; Simon I; Ayoub N
    Nat Commun; 2024 Jul; 15(1):6417. PubMed ID: 39080280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-omics analysis reveals RNA splicing alterations and their biological and clinical implications in lung adenocarcinoma.
    Wu Q; Feng L; Wang Y; Mao Y; Di X; Zhang K; Cheng S; Xiao T
    Signal Transduct Target Ther; 2022 Aug; 7(1):270. PubMed ID: 35989380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway.
    Jin X; Di X; Wang R; Ma H; Tian C; Zhao M; Cong S; Liu J; Li R; Wang K
    J Cell Mol Med; 2019 Jun; 23(6):3897-3904. PubMed ID: 30955253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
    Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue virus targets RBM10 deregulating host cell splicing and innate immune response.
    Pozzi B; Bragado L; Mammi P; Torti MF; Gaioli N; Gebhard LG; García Solá ME; Vaz-Drago R; Iglesias NG; García CC; Gamarnik AV; Srebrow A
    Nucleic Acids Res; 2020 Jul; 48(12):6824-6838. PubMed ID: 32432721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RNA-binding landscape of RBM10 and its role in alternative splicing regulation in models of mouse early development.
    Rodor J; FitzPatrick DR; Eyras E; Cáceres JF
    RNA Biol; 2017 Jan; 14(1):45-57. PubMed ID: 27763814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional insight into a neurodevelopmental disorder caused by missense variants in an RNA-binding protein, RBM10.
    Imagawa E; Moreta L; Misra VK; Newman C; Konuma T; Oishi K
    J Hum Genet; 2023 Sep; 68(9):643-648. PubMed ID: 37268768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing arrays reveal novel RBM10 targets, including SMN2 pre-mRNA.
    Sutherland LC; Thibault P; Durand M; Lapointe E; Knee JM; Beauvais A; Kalatskaya I; Hunt SC; Loiselle JJ; Roy JG; Tessier SJ; Ybazeta G; Stein L; Kothary R; Klinck R; Chabot B
    BMC Mol Biol; 2017 Jul; 18(1):19. PubMed ID: 28728573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA-binding motif protein 10 inactivates c-Myc by partnering with ribosomal proteins uL18 and uL5.
    Lee H; Jung JH; Ko HM; Park H; Segall AM; Sheffmaker RL; Wang J; Frey WD; Pham N; Wang Y; Zhang Y; Jackson JG; Zeng SX; Lu H
    Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2308292120. PubMed ID: 38032932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.